Jan 28 (Reuters) - Sonnet Biotherapeutics Holdings Inc SONN.O:
SONNET BIOTHERAPEUTICS FURTHER EXPANDS GLOBAL INTELLECTUAL PROPERTY PORTFOLIO WITH ISSUANCE OF EU PATENT FOR FHAB® PLATFORM TECHNOLOGY
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.